VEW 2024: Debunking myths in order to integrate myopia management into your practice
Brianna Rhue, OD, FAAO, FSLS, shares her passion for myopia management and control at this year's Vision Expo West.
Brightstar Therapeutics appoints Jared Young as new chief commercial officer
September 6th 2024Young will be aiding in expanding real-world evidence programs to promotion the adoption of Brightstar’s BrightMEM corneal allograft for the treatment of limbal stem cell deficiency and persistent epithelial defects.